
Chronic diseases don’t develop overnight. They build quietly through overlooked patterns, unmanaged stress, skipped meals, missed sleep, and the steady erosion of routines. While the long-term consequences are well known, the early opportunities for reducing the risk often pass by unnoticed. Joe Kiani, founder of Masimo and Willow Laboratories, has spent years focused on closing that gap. His latest innovation, Nutu™, is designed to surface those early warning moments and give users support before the cost of inaction becomes irreversible.
Much of the national conversation around healthcare costs remains on treatment. But the real economic pressure point lies earlier, at the threshold between stability and decline. Tools for reducing the risk, if properly designed and widely adopted, can make a measurable difference.
Small Delays, Big Consequences
The cost of inaction rarely appears all at once. It builds gradually through more emergency room visits, lost workdays, reduced productivity, and ultimately higher …






:max_bytes(150000):strip_icc()/GettyImages-1324374760-c79b0399a03341a3ba85ffe0858e1ae6.jpg)


